Executive Director, Clinical Informatics (CMIO)
Pediatric Infectious Disease
Dr. Harris R. Stutman, MD
Harris Stutman works in the field of Pediatric Infectious Disease. He studied medicine at Penn State College of Medicine. Harris Stutman is a published doctor as well. He has 66 publications published. The latest was: Comparison of quantitative polymerase chain reaction, acid fast bacilli smear, and culture results in patients receiving therapy for pulmonary tuberculosis.
Publications
- Organizational challenges in developing one of the Nationwide Health Information Network trial implementation awardees.
- Provider stakeholders' perceived benefit from a nascent health information exchange: a qualitative analysis.
- Voluntary physician adoption of an inpatient electronic medical record by obstetrician-gynecologists.
- Physician adoption & governance strategies for a multi-facility EMR/CPOE implementation.
- Optimizing the acceptance of medication-based alerts by physicians during CPOE implementation in a community hospital environment.
- Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial.
- Comparison of quantitative polymerase chain reaction, acid fast bacilli smear, and culture results in patients receiving therapy for pulmonary tuberculosis.
- Polymerase chain reaction for diagnosis of M. tuberculosis: comparison of simple boiling and a conventional method for DNA extraction.
- Salmonella, Shigella, and Campylobacter: common bacterial causes of infectious diarrhea.
- Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial.
- Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis.
- Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention.
- Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis.
- Vitamin A levels in children with measles in Long Beach, California.
- Diagnosis of tuberculosis: can the polymerase chain reaction replace acid-fast bacilli smear and culture?
- Phaeohyphomycosis of the maxilloethmoid sinus caused by Drechslera spicifera: a new fungal pathogen.
- Single-dose pharmacokinetics of aztreonam in pediatric patients.
- In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients.
- Hemophilus influenzae type b meningitis in infant rabbits. Pathogenesis and therapy.
- Phaeohyphomycotic infections.
- Chlamydia trachomatis as a cause of pneumonitis and pleural effusion.
- Interaction of ketoconazole with rifampin and isoniazid.
- White blood cell transfusions.
- Mycobacterium chelonei abscess.
- Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosis.
- Comparison of lysis-direct plating and broth methods for pediatric blood cultures: clinical relevance and cost effectiveness.
- Continuous versus intermittent aminoglycoside therapy.
- Aztreonam therapy for serious gram-negative infections in children.
- Therapy for bacterial meningitis: which drugs, and for how long?
- Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.
- Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis.
- Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial.
- Second episodes of Haemophilus influenzae type b disease following rifampin prophylaxis of the index patients.
- Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients.
- Drechslera, not Dreschlera.
- Pulmonary infections in children with cystic fibrosis.
- Bacterial meningitis in children: diagnosis and therapy. A review of recent developments.
- Aztreonam: the first monobactam antibiotic.
- Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.
- Stevens-Johnson syndrome and Mycoplasma pneumoniae: evidence for cutaneous infection.
- Clinical experience with aztreonam.
- Aztreonam: clinical pharmacology.
- Routine viral culture for pediatric respiratory specimens submitted for direct immunofluorescence testing.
- In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.
- New data on clinical efficacy of ribavirin.
- Invasive Haemophilus influenzae type B infections: a continuing challenge.
- Parainfluenza type 3 meningitis. Report of two cases and review of the literature.
- Ribavirin: adverse drug reactions, 1986 to 1988.
- Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.
- In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum.
- Clinical experience with aztreonam for treatment of infections in children.
- Current issues in burn wound infections.
- Detection of anti-BCG secreting cells in cerebrospinal fluid.
- Comparative trial of cefprozil vs. amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion.
- In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid.
- Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.
- Coxsackie B2 meningitis with unusually high white blood cell count in cerebrospinal fluid.
- In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients.
- Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
- In vitro activity of teicoplanin compared with vancomycin against methicillin-resistant Staphylococcus aureus derived from cystic fibrosis sputum.
- Toxin-related diarrheas.
- Bacterial arthritis caused by Corynebacterium diphtheriae.
- Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infection.
- Cefprozil.
- Quantitative-competitive polymerase chain reaction for rapid susceptibility testing of Mycobacterium tuberculosis to isoniazid.
Schools
Pennsylvania State University College of Medicine
Chldns Hospital
Oklahoma University Med Center
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Infectious Disease
Accepted Insurances
Education
-
U Oklahoma -
Penn State College of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Nancy D. Dodd, MD
 This Doctor is OpenDoctor Recommended.
|